| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/23/2006 | US20060040857 1-Desamino-8-a-arginyl vasopressin analogs |
| 02/23/2006 | US20060040855 Low efficacy gonadotropin agonists and antagonists |
| 02/23/2006 | US20060040851 Gag-peptide complex |
| 02/23/2006 | US20060040382 Tagged epitope protein transposable element |
| 02/23/2006 | US20060040371 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 02/23/2006 | US20060040362 Recombinant human Mannan-Building Proteins |
| 02/23/2006 | US20060040361 Protective antigens and vaccines for the control of multi species tick infestations |
| 02/23/2006 | US20060040360 Adipocyte complement related protein homolog zacrp7 |
| 02/23/2006 | US20060040359 Oxidation-reduction sensitive green fluorescent protein variants |
| 02/23/2006 | US20060040358 IGF-1 receptor interacting proteins |
| 02/23/2006 | US20060040357 Novel nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor |
| 02/23/2006 | US20060040356 Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins |
| 02/23/2006 | US20060040352 Expression of mammalian proteins in Pseudomonas fluorescens |
| 02/23/2006 | US20060040351 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/23/2006 | US20060040350 DNA which encodes the receptor, a transformed cell expressing the receptor, for producing the receptor, for identifying an agonist, antagonist, or allosteric modulator for glutamic acid |
| 02/23/2006 | US20060040349 Thermophilic hydrophobin proteins and applications for surface modification |
| 02/23/2006 | US20060040347 Use of triplex structure DNA in transferring nucleotide sequences |
| 02/23/2006 | US20060040346 Bacterial bioreactor for propagation of enzymatic polypeptides |
| 02/23/2006 | US20060040332 novel Class I HLA-A2 and Class II HLA-DR4-restricted epitopes and methods for their use in detecting T-cells in peripheral blood specific for infection or latency of mycobacterial infection, including M. tuberculosis and M. leprae as others |
| 02/23/2006 | US20060040328 Screening for a material that promotes or inhibits binding between a rabconnectin-3-binding protein having a specific amino acid sequence and rabconnectin-3 and therefore would be useful for regulating Ca2+-dependent exocytosis |
| 02/23/2006 | US20060040321 Orphan receptor TLX and uses therefor |
| 02/23/2006 | US20060040316 Using transforming growth factor-beta -activated kinase-1 (TAK-1) and TAK1 binding protein 1(TAB-1) as evaluative tool in detection of modulators of interleukin and tumor necrosis factor activities |
| 02/23/2006 | US20060040313 Human chemokine beta-9 |
| 02/23/2006 | US20060040312 Uses of kappa-conotoxin PVIIA |
| 02/23/2006 | US20060040310 Epitope testing using soluble HLA |
| 02/23/2006 | US20060040307 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 02/23/2006 | US20060040306 81588 methods and compositions of human proteins and uses thereof |
| 02/23/2006 | US20060040302 Methods of classifying, diagnosing, stratifying and treating cancer patients and their tumors |
| 02/23/2006 | US20060040298 Rhesus monkey NURR1 nuclear receptor |
| 02/23/2006 | US20060040285 Used in diagnosis; small cell lung cancer, lung adenocarcinoma, T-cell lymophoblastic lymphoma, glioblastoma, gastric carcinoma, colon adenocarcinoma, prostate carcinoma, pancreatic carcinoma, esophagus epidermoid carcinoma and promonocytic leukemia |
| 02/23/2006 | US20060040284 TMS1 compositions and methods of use |
| 02/23/2006 | US20060040279 DNA chips used for bioprocess control |
| 02/23/2006 | US20060040278 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer |
| 02/23/2006 | US20060040277 Nucleic sequences encoding an AT2 receptor-interacting protein (ATIP) and their applications |
| 02/23/2006 | US20060040267 Transcriptional activator |
| 02/23/2006 | US20060040264 Means for identifying neisseria meningitidis-specific genes |
| 02/23/2006 | US20060040262 Novel compositions and methods in cancer |
| 02/23/2006 | US20060040259 Administering an inhibitor of prenyl cysteine methyltransferase; inhibiting the prenylation or a post-prenylation reaction of a protein contained in the virus infecting a subject |
| 02/23/2006 | US20060040255 Cell line designated KT-1 established from tongue epithelial and use thereof |
| 02/23/2006 | US20060039929 Chimera botulinum toxin type E |
| 02/23/2006 | US20060039928 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/23/2006 | US20060039925 Mutants of streptococcal toxin a and methods of use |
| 02/23/2006 | US20060039924 Peptide having modified arginine residue; detecting autoimmune antibodies against rheumatoid arthritis |
| 02/23/2006 | US20060039922 Streptococcal heat shock proteins of the Hsp60 family |
| 02/23/2006 | US20060039921 Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |
| 02/23/2006 | US20060039920 Immunization, scrub typhus of tsutsugamushi disease, HIV |
| 02/23/2006 | US20060039919 an E7 peptide sequence of human papillomavirus type 16, a translocation peptide and a peptide within a carboxyl terminal fragments, used for inhibiting urogenital cancers induced or caused by HPV type 16 |
| 02/23/2006 | US20060039918 Stress proteins and peptides and methods of use thereof |
| 02/23/2006 | US20060039909 Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes |
| 02/23/2006 | US20060039905 Galectin 11 |
| 02/23/2006 | US20060039903 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 02/23/2006 | US20060039893 Expression vector includes insert of dna which codes for exogenous protein and adenovirus dna having deletion from nucleotides 356-4020; production of recombinant proteins; gene therapy against tumors and cancer |
| 02/23/2006 | US20060039884 Baldness related gene and the polypeptide encoded thereby , and uses |
| 02/23/2006 | US20060039859 using three functional constituents e.g. an amyloid targeted-peptide sequence; a linker moiety; and a peptide-based chelation core(e.g. diethylenetriaminepentaacetic acid DTPA, EDTA) for incorporation of technetium-99m for medical imaging; conjugate binds to amyloid plaques associataed with Alzheimer |
| 02/23/2006 | DE20023745U1 Method of modulating expression of an endogenous cellular gene in a cell to prevent gene activation or prevent repression of gene expression comprising contacting a target sequence with a zinc finger protein |
| 02/23/2006 | DE102004040134A1 Neue essentielle Gene von Bacillus licheniformis und darauf aufbauende verbesserte biotechnologische Produktionsverfahren New essential genes from Bacillus licheniformis, upon which improved biotechnological production |
| 02/23/2006 | DE102004039537A1 Vernetzte Kollagenmatrix zur Herstellung eines Hautäquivalentes Cross-linked collagen matrix for the preparation of a skin equivalent |
| 02/23/2006 | CA2777686A1 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 02/23/2006 | CA2577660A1 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 02/23/2006 | CA2577597A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor |
| 02/23/2006 | CA2576296A1 Nucleic acids conferring lipid and sugar alterations in plants ii |
| 02/23/2006 | CA2575387A1 Novel peptide and pharmaceutical composition containing said peptide |
| 02/23/2006 | CA2575368A1 Cloning and expression of recombinant adhesive protein mefp-1 of the blue mussel, mytilus edulis |
| 02/23/2006 | CA2575058A1 Antimicrobial peptides comprising an arginine- and/or lysine-containing motif |
| 02/23/2006 | CA2574007A1 Apolipoprotein a1 mimetics and uses thereof |
| 02/23/2006 | CA2572671A1 Cytoxan antibodies and immunoassay |
| 02/23/2006 | CA2571942A1 Compositions and methods of purifying myelin-associated glycoprotein (mag) |
| 02/23/2006 | CA2569235A1 Anti-ghrelin antibodies |
| 02/22/2006 | EP1627919A1 An infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| 02/22/2006 | EP1627918A1 Antagonists of interleukin-15 |
| 02/22/2006 | EP1627917A1 NUCLEIC ACID CONSTRUCT CONTAINING HEPATITIS C VIRUS (HCV) OF GENOCYPE 2a GENOME-ORIGIN NUCLEIC ACID AND CELL HAVING THE NUCLEIC ACID CONSTRUCT TRANSFERRED THEREINTO |
| 02/22/2006 | EP1627887A2 Mouce trace amine associated receptors |
| 02/22/2006 | EP1627886A1 Polypeptide, cDNA encoding the same, and use of them |
| 02/22/2006 | EP1627885A1 Polypeptide capable of assisting digestive organ absorption |
| 02/22/2006 | EP1627643A2 Vascular endothelial cell growth factor antagonists |
| 02/22/2006 | EP1627642A2 Zinc free insulin crystals for use in pulmonary compositions |
| 02/22/2006 | EP1627563A1 Means and methods for producing a stabilized cell of interest |
| 02/22/2006 | EP1627231A2 Improvements to gamma delta t cell-mediated therapy |
| 02/22/2006 | EP1627229A2 Methods and compositions for modulating the interaction between adiponectin and its receptor |
| 02/22/2006 | EP1627226A1 Methods for protein labeling based on acyl carrier protein |
| 02/22/2006 | EP1627217A2 Cdkl1 as modifier of branching morphogenesis and methods of use |
| 02/22/2006 | EP1627073A2 Use of a biotinylated polypeptide for determining the activity of protein-phosphorylating enzymes |
| 02/22/2006 | EP1627067A1 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype b |
| 02/22/2006 | EP1627064A1 Flowering inhibition |
| 02/22/2006 | EP1627063A1 Flowering induction |
| 02/22/2006 | EP1627059A2 Recombinant comamonas testosteroni 5-mgam-4d; amids and carboxylic acid production |
| 02/22/2006 | EP1627056A1 Novel il-8-like polypeptides |
| 02/22/2006 | EP1627051A2 Regulation of acheron expression |
| 02/22/2006 | EP1627049A2 Novel trichoderma genes |
| 02/22/2006 | EP1627043A2 Mapk7 as modifier of branching morphogenesis and methods of use |
| 02/22/2006 | EP1627042A2 Map2k6 as modifier of branching morphogenensis and methods of use |
| 02/22/2006 | EP1626989A2 Method of treating corneal transplant rejection by using vegf antagonists |
| 02/22/2006 | EP1626988A2 Intron fusion proteins, and methods of identifying and using same |
| 02/22/2006 | EP1626986A2 Secreted polypeptide species associated with cardiovascular disorders |
| 02/22/2006 | EP1626985A1 Generation of artificial binding proteins based on ubiquitin proteins |
| 02/22/2006 | EP1626984A1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease |
| 02/22/2006 | EP1626983A2 Novel poly (ethylene glycol) modified erythropoietin agonists and uses thereof |
| 02/22/2006 | EP1626982A2 Metal chelate complexes immobilized on solid supports for peptide preparation |
| 02/22/2006 | EP1626981A2 Dipeptidyl-peptidase protected proteins |
| 02/22/2006 | EP1626733A2 Prokaryotic collagen-like proteins and uses thereof |